Skyepharma has marked six months of activity at its MMPP (Medicines to be Handled with Particular Care) facility, dedicated to the development and production of high-potency oral oncology drugs. The French CDMO has shared early achievements from the site, located in
SKYEPHARMA Contract Manufacturing & Development (CDMO) Profile Skyepharma is a France-based CDMO expert in the formulation and manufacturing of complex oral solids (controlled release, multilayer, oncology & HPAPI, controlled substances, rare disease, etc). We also develop our own innovation pipeline
Skyepharma is a fully-integrated CDMO specialised in formulating, developing and producing complex oral dosage forms and expanding into Bioproduction with the opening of their new SkyeHub plant. Based outside Lyon, France, the company offers their worldwide customer base a full
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
